作者：
Marta,Bodro [1]
;
Carlos,Cervera [2]
;
Laura,Linares [1]
;
Belén,Suárez [3]
;
Jaume,Llopis [1]
;
Gemma,Sanclemente [1]
;
Sergi,Casadó-Llombart [4]
;
Mario,Fernández-Ruiz [5]
;
María Carmen,Fariñas [6]
;
Sara,Cantisan [7]
;
Miguel,Montejo [8]
;
Elisa,Cordero [9]
;
Isabel,Oriol [10]
;
María Angeles,Marcos [11]
;
Francisco,Lozano [12]
;
Asunción,Moreno [1]
;
GESITRA-IC/SEIMC/REIPI investigators [3]
作者单位：
Infectious Diseases Department, Hospital Clinic de Barcelona - Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
[1]
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
[2]
Immunology Department, Biomedical Diagnostic Center, Hospital Clínic de Barcelona, Barcelona, Spain.
[3]
Immunoreceptors of the Innate and Adaptive Sistems, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
[4]
Hospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (imas12), Madrid, Spain.
[5]
University Hospital "Marqués de Valdecilla", Instituto de Investigación "Marqués de Valdecilla" (IDIVAL), University of Cantabria, Santander, Spain.
[6]
Reina Sofía University Hospital, University of Cordoba, Cordoba, Spain.
[7]
Hospital Universitario Cruces, Barakaldo, Universidad del País Vasco, Bilbao, Spain.
[8]
Unit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain.
[9]
Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain.
[10]
Department of Medicine, University of Seville, Seville, Spain.
[11]
University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
[12]
Biomedicine Department, University of Barcelona, Barcelona, Spain.
[13]
DOI
10.3389/fimmu.2022.897912
PMID
36016941
发布时间
2022-08-29
换一批
换一批
